Expression of recombinant human cyclooxygenase isoenzymes in transfected COS-7 cells in vitro and inhibition by tenoxicam, indomethacin and aspirin.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Prostaglandins, Leukotrienes and Essential Fatty Acids

• Publication date

  1997-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0952-3278(97)90584-6PMID 9175172
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tenoxicam

  2012cited by this paper
• New insights into the mode of action of anti-inflammatory drugs

  2005cited by this paper
• Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.

  1994cited by this paper
• Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.

  1994cited by this paper
• High-level expression of active human cyclooxygenase-2 in insect cells.

  1994cited by this paper
• Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

  1994cited by this paper
• Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation.

  1994cited by this paper
• Selective inhibition of cyclooxygenase 2.

  1994cited by this paper
• Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin.

  1994cited by this paper
• NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.

  1994cited by this paper
• Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.

  1994cited by this paper
• Clinical Pharmacokinetics of Tenoxicam

  1994cited by this paper
• Structure of the human cyclo-oxygenase-2 gene.

  1994cited by this paper
• Expression of prostaglandin endoperoxide synthase-1 and prostaglandin endoperoxide synthase-2 in human osteoblasts.

  1994cited by this paper
• Mutation of serine‐516 in human prostaglandin G/H synthase‐2 to methionine or aspirin acetylation of this residue stimulates 15‐R‐HETE synthesis

  1994cited by this paper
• Studies on the induction of cyclooxygenase isozymes by various prostaglandins in mouse osteoblastic cell line with reference to signal transduction pathways.

  1994cited by this paper
• Transforming growth factor β1 augments mitogen‐induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene both in swiss 3T3 cells and in murine embryo fibroblasts

  1994cited by this paper
• Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.

  1993cited by this paper
• Chloroquine-induced inhibition of the production of TNF, but not of IL-6, is affected by disruption of iron metabolism.

  1993cited by this paper
• Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.

  1993cited by this paper
• Prostaglandin endoperoxide synthase. The aspirin acetylation region.

  1992cited by this paper
• Human cyclooxygenase-2 cDNA.

  1992cited by this paper
• Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase.

  1992cited by this paper
• cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase.

  1992cited by this paper
• Prostanoid biosynthesis and mechanisms of action.

  1992cited by this paper
• Mitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs

  1992cited by this paper
• Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment

  1991cited by this paper
• TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

  1991cited by this paper
• A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein.

  1991cited by this paper
• Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.

  1991cited by this paper
• The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases.

  1990cited by this paper
• Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice.

  1990cited by this paper
• Identification of a cyclooxygenase-related gene and its potential role in prostaglandin formation.

  1989cited by this paper
• Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme.

  1989cited by this paper
• Tenoxicam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

  1987cited by this paper
• Pentoxifylline

  1987cited by this paper
• Effects of non-steroidal anti-inflammatory drugs on fatty acid cyclooxygenase and prostaglandin hydroperoxidase activities.

  1982cited by this paper
• Multiple sites on prostaglandin cyclooxygenase are determinants in the action of nonsteroidal antiinflammatory agents.

  1981cited by this paper
• Acetylation of prostaglandin endoperoxide synthetase with acetylsalicylic acid.

  1980cited by this paper
• A radioimmunoassay for 6-keto-prostaglandin F1 alpha.

  1980cited by this paper
• A radioimmunoassay for 6-keto-prostaglandin F1alpha.

  1978cited by this paper
• A radioimmunoassay for 6-keto- prostaglandin F1α

  1978cited by this paper
• The Pharmacological Basis of Therapeutics

  1976cited by this paper
• Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs.

  1975cited by this paper
• Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

  1971cited by this paper

• Discovery of pyrazole N-aryl sulfonate: A novel and highly potent cyclooxygenase-2 (COX-2) selective inhibitors.

  2021cites this paper
• New applied pharmacological approach/trend on utilization of agro-industrial wastes

  2018cites this paper
• Modulation of the pharmacological properties of meloxicam by octreotide in rats

  2015cites this paper
• Preclinical Predictors of Anticancer Drug Efficacy: Critical Assessment with Emphasis on Whether Nanomolar Potency Should Be Required of Candidate Agents

  2012cites this paper
• Comparison of pharmacokinetic and pharmacodynamic profiles of aspirin following oral gavage and diet dosing in rats.

  2009cites this paper
• Anti-inflammatory effects of a triterpenoid isolated from Wilbrandia ebracteata Cogn.

  2007cites this paper
• Comparative study of anti-inflammatory and ulcerogenic activities of different cyclo-oxygenase inhibitors

  2006cites this paper
• The involvement of nuclear factor-kappa B in cyclooxygenase-2 overexpression in murine colon cancer cells transduced with herpes simplex virus thymidine kinase gene

  2006cites this paper
• Clinical tolerability of perioperative tenoxicam in 1001 patients – a prospective, controlled, double‐blind, multi‐centre study

  2004influential citation
• The Development of Drugs That Target Cyclooxygenase-2

  2003cites this paper
• Nitric oxide and cyclooxygenase may participate in the analgesic and anti-inflammatory effect of the cucurbitacins fraction from Wilbrandia ebracteata.

  2003cites this paper
• A comparative study of the antipyretic effects of indomethacin and dipyrone in rats

  2002cites this paper
• Saure antipyretische Analgetika

  2001cites this paper
• Anti-inflammatory effects of the products from Wilbrandia ebracteata on carrageenan-induced pleurisy in mice.

  1999cites this paper
• Kinetic basis for selective inhibition of cyclo-oxygenases.

  1999cites this paper
• Systematic pharmacological approach to the characterization of NSAIDs.

  1998cites this paper